BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5554467)

  • 1. Influence of 4,4'-(isopropylidenedithio)bis(2,6-di-t-butylphenol) (DH-581) on experimental atherosclerosis in rabbits.
    Kritchevsky D; Kim HK; Tepper SA
    Proc Soc Exp Biol Med; 1971 Apr; 136(4):1216-21. PubMed ID: 5554467
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypocholesterolemic effect of 4,4'-(isopropylidenedithio)-bis(2,6-di-t-butylphenol) (probucol).
    Barnhart JW; Sefranka JA; McIntosh DD
    Am J Clin Nutr; 1970 Sep; 23(9):1229-33. PubMed ID: 5450842
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of [4,4'-(isopropylidenethio)bis(2,6-di-t-butylphenol)] (DH-581) on serum lipids and lipoproteins in human subjects.
    Drake JW; Bradford RH; McDearmon M; Furman RH
    Metabolism; 1969 Nov; 18(11):916-25. PubMed ID: 5350556
    [No Abstract]   [Full Text] [Related]  

  • 4. Laboratory studies of 1-methyl-4-piperidyl bis(p-chlorophenoxy) acetate (SaH 42-348)--a new hypolipidemic agent.
    Timms AR; Kelly LA; Ho RS; Trapold JH
    Biochem Pharmacol; 1969 Aug; 18(8):1861-71. PubMed ID: 5811622
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of nicotinic acid and pentaerythritolteranicotinate upon experimental atherosclerosis in the rabbit.
    Brattsand R; Lundholm L
    Atherosclerosis; 1971; 14(1):91-105. PubMed ID: 5130977
    [No Abstract]   [Full Text] [Related]  

  • 6. The additive effects of clofibrate and probucol (DH-581) on rat serum cholesterol.
    Duncan CH; Best MM
    Atherosclerosis; 1973; 17(2):161-6. PubMed ID: 4709117
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of atromide on the endogenously-induced experimental hypercholesteremia and development lipoidosis of the aorta in rabbits].
    Metelitsa VI; Sverdlova PS; Aleksandrov AA; Zakharova MP; Daragan AG
    Kardiologiia; 1970 Sep; 10(9):25-9. PubMed ID: 5501510
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term oral administration of probucol (4,4'-(isopropylidenedithio) bis(2,6-di-t-butylphenol)) (DH-581) in the management of hypercholesterolemia.
    Harris RS; Gilmore HR; Bricker LA; Kiem IM; Rubin E
    J Am Geriatr Soc; 1974 Apr; 22(4):167-75. PubMed ID: 4594122
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of ethyl p-chlorophenoxyisobutyrate (CPIB) upon establishment and progression of experimental atherosclerosis in rabbits.
    Kritchevsky D; Sallata P; Tepper SA
    J Atheroscler Res; 1968; 8(5):755-61. PubMed ID: 5688373
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacology of probucol. I].
    Donatelli L
    Clin Ter; 1984 Mar; 108(5):367-88. PubMed ID: 6232074
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on new nicotinic acid ester derivatives. 6. Serum cholesterol level lowering effect of 2,2,6,6-tetrakis(nicotinoyloxymethyl) cyclohexanol (K-31).
    Aso Y; Abe Y; Higo K; Naruke T; Irikura T
    J Atheroscler Res; 1969; 10(3):391-401. PubMed ID: 5364087
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of mevinolin on experimental atherosclerosis in rabbits.
    Kritchevsky D; Tepper SA; Klurfeld DM
    Pharmacol Res Commun; 1981 Nov; 13(10):921-6. PubMed ID: 6918018
    [No Abstract]   [Full Text] [Related]  

  • 13. Action of the urinary antisteroid substance in experimental atheromatosis.
    Damian E; Ianăş O; Bădescu I
    Rev Roum Med; 1974; 12(3):185-8. PubMed ID: 4460213
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of colestipol (U-26,597A) on experimental atherosclerosis in rabbits.
    Kritchevsky D; Kim HK; Tepper SA
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):185-8. PubMed ID: 4683239
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of established atherosclerosis and xanthomas in mature WHHL rabbits by keeping their serum cholesterol levels extremely low. Effect of pravastatin sodium in combination with cholestyramine.
    Shiomi M; Ito T; Watanabe Y; Tsujita Y; Kuroda M; Arai M; Fukami M; Fukushige J; Tamura A
    Atherosclerosis; 1990 Jul; 83(1):69-80. PubMed ID: 2117930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental atherosclerosis with ascorbic acid deficiency.
    Fujinami T; Okado K; Senda K; Sugimura M; Kishikawa M
    Jpn Circ J; 1971 Dec; 35(12):1559-65. PubMed ID: 5172476
    [No Abstract]   [Full Text] [Related]  

  • 17. Phospholipids in experimental atherosclerosis.
    Altman RF; de Mendonça JM; Schaeffer GM; de Souza JR; Bandoli JG; da Silva DJ; Lopes CR
    Arzneimittelforschung; 1974 Jan; 24(1):11-6. PubMed ID: 4406098
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of the ethyl ester and sodium salt of alpha-p-chlorophenoxyisobutyric acid on cholesterol oxidation by rat liver mitochondria.
    Kritchevsky D; Tepper SA; Sallata P; Kabakjian JR; Cristofalo VJ
    Proc Soc Exp Biol Med; 1969 Oct; 132(1):79-82. PubMed ID: 5344871
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe pulmonary atherosclerosis in hypercholesterolemic rabbits.
    Child GV; Thurlbeck WM; Weigensberg BI
    Arch Pathol; 1974 Jul; 98(1):47-50. PubMed ID: 4829775
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of elastoproteinase on experimental atheromatosis in rabbits.
    Loeven WA
    Eur J Pharmacol; 1967 May; 1(3):254-61. PubMed ID: 6058910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.